The Japan Times report that A leading researcher into severe spinal cord injuries says trials for stem cell therapy have shown groundbreaking results in giving immobile patients the ability to walk again.
The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibers.
|
-->
|
Wise Young, the chief executive officer of China Spinal Cord Injury Network said that on average, 15 out of 20 patients in the Chinese city of Kunming who received umbilical cord blood cell transplants and intensive walking therapy were able to walk with minimal assistance seven years after complete spinal cord injury.
Each component of the combination therapy will be tested in the third phase, which Young said would involve 120 patients in China and another 120 across India, Norway and the United States.
-->
Source: http://www.japantimes.co.jp/
0 comments:
Post a Comment